Scarica l'app Stockscreener
16.28
0.61%
-0.10
Dopo l'orario di chiusura:
16.50
0.22
+1.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DNLI Giù?
Forum
Previsione
Precedente Chiudi:
$16.38
Aprire:
$16.25
Volume 24 ore:
1.23M
Relative Volume:
0.64
Capitalizzazione di mercato:
$2.38B
Reddito:
$340.81M
Utile/perdita netta:
$-419.65M
Rapporto P/E:
-5.7123
EPS:
-2.85
Flusso di cassa netto:
$-402.10M
1 W Prestazione:
+2.01%
1M Prestazione:
+12.12%
6M Prestazione:
-2.22%
1 anno Prestazione:
-37.29%
Intervallo 1D:
$15.90
$16.45
Intervallo di 1 settimana:
$15.90
$17.02
Portata 52W:
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
Nome
Denali Therapeutics Inc
Settore
Industria
Telefono
(650) 866-8547
Indirizzo
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
Confronta DNLI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
16.28 | 2.39B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | Ripresa | Morgan Stanley | Overweight |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2025-01-07 | Iniziato | Robert W. Baird | Outperform |
| 2025-01-03 | Iniziato | William Blair | Outperform |
| 2024-12-16 | Aggiornamento | Stifel | Hold → Buy |
| 2024-10-10 | Ripresa | Raymond James | Mkt Perform |
| 2024-10-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-09-06 | Iniziato | B. Riley Securities | Buy |
| 2023-01-30 | Iniziato | SVB Securities | Outperform |
| 2022-12-05 | Iniziato | Cowen | Outperform |
| 2022-11-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-02 | Iniziato | BofA Securities | Buy |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-12-10 | Ripresa | Raymond James | Mkt Perform |
| 2021-09-21 | Iniziato | Oppenheimer | Outperform |
| 2021-09-01 | Iniziato | SMBC Nikko | Outperform |
| 2021-05-18 | Iniziato | UBS | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-02-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-02-24 | Iniziato | Jefferies | Buy |
| 2020-02-19 | Iniziato | Stifel | Hold |
| 2020-01-27 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-09-26 | Iniziato | Wedbush | Neutral |
| 2019-09-13 | Iniziato | Nomura | Buy |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Iniziato | Janney | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-01-02 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Iniziato | Goldman | Neutral |
| 2018-01-02 | Iniziato | JP Morgan | Overweight |
| 2018-01-02 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Denali Therapeutics Inc Borsa (DNLI) Ultime notizie
Comparing Denali Therapeutics Inc. in custom built stock radarsWeekly Trade Review & Real-Time Volume Analysis - newser.com
Why analysts remain bullish on Denali Therapeutics Inc. stockPrice Action & Growth Focused Investment Plans - newser.com
Is Denali Therapeutics Inc. stock a top momentum playGlobal Markets & Accurate Trade Setup Notifications - newser.com
Can Denali Therapeutics Inc. (4DN) stock test all time highsJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Is Denali Therapeutics Inc. stock a contrarian buyStop Loss & Growth Focused Investment Plans - newser.com
Pier Capital LLC Sells 20,708 Shares of Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
Published on: 2025-11-02 03:18:16 - newser.com
Will Denali Therapeutics Inc. (4DN) stock enhance shareholder valueStock Surge & Free Safe Entry Trade Signal Reports - newser.com
Detecting price anomalies in Denali Therapeutics Inc. with AIPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com
Is Denali Therapeutics Inc. stock ready for a breakoutGDP Growth & Consistent Profit Trade Alerts - newser.com
Will Denali Therapeutics Inc. (4DN) stock outperform small cap peers2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
Is Denali Therapeutics Inc. stock a dividend growth opportunityQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Savvy Advisors Inc. Invests $1.37 Million in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc expected to post a loss of 75 cents a shareEarnings Preview - TradingView
Applying sector rotation models to Denali Therapeutics Inc.Fed Meeting & Safe Capital Growth Stock Tips - newser.com
Does Denali Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesShort Setup & Verified Swing Trading Watchlists - newser.com
Will Denali Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
How Denali Therapeutics Inc. (4DN) stock gains from tech spendingEarnings Risk Report & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-10-30 23:48:28 - newser.com
Denali Therapeutics (DNLI) to Release Quarterly Earnings on Wednesday - MarketBeat
Published on: 2025-10-29 04:42:36 - newser.com
Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):